出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2014/05/11 11:02:34」(JST)
It has been suggested that this article be merged with Kininogen 1. (Discuss) Proposed since November 2011. |
kininogen 1 | |
---|---|
Identifiers | |
Symbol | KNG1 |
Alt. symbols | KNG, BDK |
Entrez | 3827 |
HUGO | 6383 |
OMIM | 612358 |
RefSeq | NM_001102416 |
UniProt | P01042 |
Other data | |
Locus | Chr. 3 q21-qter |
High molecular weight kininogen (HMWK or HK) is a circulating plasma protein which participates in the initiation of blood coagulation, and in the generation of the vasodilator bradykinin via the Kallikrein-kinin system. HMWK is inactive until it either adheres to binding proteins beneath an endothelium disrupted by injury, thereby initiating coagulation; or it binds to intact endothelial cells or platelets for functions other than coagulation.
In the past, HMWK has been called HMWK-kallikrein factor, Flaujeac factor (1975),[1] Fitzgerald factor (1975),[2] and Williams-Fitzgerald-Flaujeac factor, - the eponyms being for people first reported to have HMWK deficiency. Its current accepted name is to contrast it with low molecular weight kininogen (LMWK) which has a similar function to HMWK in the tissue (as opposed to serum) kinin-kallikrein system.
HMWK is an alpha-globulin with six functional domains. It circulates as a single-chain 626 amino acid polypeptide . The heavy chain contains domains 1, 2, and 3; the light chain, domains 5 and 6. Domain 4 links the heavy and light chains.
The domains contain the following functional sites:
HMWK is one of four proteins which interact to initiate the contact activation pathway (also called the intrinsic pathway) of coagulation: the other three are Factor XII, Factor XI and prekallikrein. HMWK is not enzymatically active, and functions only as a cofactor for the activation of kallikrein and factor XII. It is also necessary for the activation of factor XI by factor XIIa.
HMWK is also a precursor of bradykinin;[3] this vasodilator is released through positive feedback by kallikrein.
HMWK is a strong inhibitor of cysteine proteinases. Responsible for this activity are domains 2 and 3 on its heavy chain.[4]
The gene for both LMWK and HMWK is located on the 3rd chromosome (3q26).[5]
Measurement of HMWK is usually done with mixing studies, in which plasma deficient in HMWK is mixed with the patient's sample and a partial thromboplastin time (PTT) is determined. Results are expressed in % of normal - a value under 60% indicates a deficiency.
The existence of HMWK was hypothesised in 1975 when several patients were described with a deficiency of a class of plasma protein and a prolonged bleeding time and PTT.[6] There is no increased risk of bleeding or any other symptoms, so the deficiency is a trait, not a disease.
|
|
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
リンク元 | 「高分子キニノゲン」 |
拡張検索 | 「high molecular weight kininogen deficiency」「high-molecular-weight kininogen deficiency」「high-molecular-weight kininogen」 |
関連記事 | 「high」「weigh」「molecular」「weighted」「molecular weight」 |
.